First Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens Medical School, Laiko General Hospital, Athens, Greece.
Second Department of Internal Medicine, Research Unit and Diabetes Centre, National and Kapodistrian University of Athens Medical School, Attikon Hospital, Athens, Greece.
J Diabetes Res. 2020 Oct 12;2020:7489795. doi: 10.1155/2020/7489795. eCollection 2020.
Oxidative stress (OS) is defined as a disturbance in the prooxidant-antioxidant balance of the cell, in favor of the former, which results in the antioxidant capacity of the cell to be overpowered. Excess reactive oxygen species (ROS) production is very harmful to cell constituents, especially proteins, lipids, and DNA, thus causing damage to the cell. Oxidative stress has been associated with a variety of pathologic conditions, including diabetes mellitus (DM), cancer, atherosclerosis, neurodegenerative diseases, rheumatoid arthritis, ischemia/reperfusion injury, obstructive sleep apnea, and accelerated aging. Regarding DM specifically, previous experimental and clinical studies have pointed to the fact that oxidative stress probably plays a major role in the pathogenesis and development of diabetic complications. It is postulated that hyperglycemia induces free radicals and impairs endogenous antioxidant defense systems through several different mechanisms. In particular, hyperglycemia promotes the creation of advanced glycation end-products (AGEs), the activation of protein kinase C (PKC), and the hyperactivity of hexosamine and sorbitol pathways, leading to the development of insulin resistance, impaired insulin secretion, and endothelial dysfunction, by inducing excessive ROS production and OS. Furthermore, glucose variability has been associated with OS as well, and recent evidence suggests that also hypoglycemia may be playing an important role in favoring diabetic vascular complications through OS, inflammation, prothrombotic events, and endothelial dysfunction. The association of these diabetic parameters (i.e., hyperglycemia, glucose variability, and hypoglycemia) with oxidative stress will be reviewed here.
氧化应激(OS)被定义为细胞内的促氧化剂-抗氧化剂平衡紊乱,有利于前者,从而导致细胞的抗氧化能力被超过。过量的活性氧(ROS)的产生对细胞成分非常有害,特别是蛋白质、脂质和 DNA,从而导致细胞损伤。氧化应激与多种病理状况有关,包括糖尿病(DM)、癌症、动脉粥样硬化、神经退行性疾病、类风湿性关节炎、缺血/再灌注损伤、阻塞性睡眠呼吸暂停和加速衰老。具体针对 DM,以前的实验和临床研究指出,氧化应激可能在糖尿病并发症的发病机制和发展中起主要作用。据推测,高血糖通过几种不同的机制诱导自由基并损害内源性抗氧化防御系统。特别是,高血糖促进了高级糖基化终产物(AGEs)的产生、蛋白激酶 C(PKC)的激活以及己糖胺和山梨醇途径的过度活跃,导致胰岛素抵抗、胰岛素分泌受损和内皮功能障碍的发展,通过诱导过多的 ROS 产生和 OS。此外,葡萄糖变异性也与 OS 有关,最近的证据表明,低血糖也可能通过 OS、炎症、促血栓形成事件和内皮功能障碍在促进糖尿病血管并发症方面发挥重要作用。这里将回顾这些糖尿病参数(即高血糖、葡萄糖变异性和低血糖)与氧化应激的关系。